Published in Br Med J on June 30, 1973
Complement and meningococcal infection. Br Med J (1976) 2.28
Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis (1987) 1.63
Comparative study of group A and group C meningococcal infection. Arch Dis Child (1977) 1.25
Circulating immune complexes in a patient with meningococcal disease. Br Med J (1976) 1.23
Nature of the antigen present in the cerebrospinal fluid and serum of patients with group A meningococcal meningitis. Clin Exp Immunol (1974) 1.18
Arthritis after meningococcal meningitis. Br Med J (1977) 1.16
Clinical features of meningococcal arthritis: a report of four cases. Ann Rheum Dis (1985) 1.16
Immune complexes in human diseases: a review. Am J Pathol (1980) 1.05
Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens. Infect Immun (1983) 1.00
Post-infectious disease syndrome. Postgrad Med J (1988) 0.95
Steroid-responsive vasculitis and arthritis in meningococcal septicaemia. Postgrad Med J (1980) 0.85
Immune complexes and the pathogenesis of meningococcal arthritis. Clin Exp Immunol (1985) 0.82
Invasive meningococcal disease presenting as Henoch-Schonlein purpura. Eur J Clin Microbiol Infect Dis (2004) 0.82
Meningococcal septicaemia and meningitis: a rising tide. Br Med J (Clin Res Ed) (1988) 0.77
Meningococcal septicaemia presenting as drug hypersensitivity. J R Soc Med (1986) 0.77
Immune complex reaction after successful treatment of meningococcal disease: an excellent response to IVIG. Rheumatol Int (2010) 0.75
Guillain-Barré syndrome following meningococcal meningitis. Postgrad Med J (1995) 0.75
[Parainfectious optic neuritis with macular infiltrate in Neisseria meningitidis B meningitis]. Ophthalmologe (2016) 0.75
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Averting a malaria disaster. Lancet (1999) 9.40
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14
Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. Lancet (1971) 6.05
Immunological phenomena in leprosy and related diseases. Adv Immunol (1971) 5.55
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature (1992) 3.93
Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64
Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg (1994) 3.58
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40
Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health (1998) 3.38
Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med (1977) 3.27
Autoimmune disease and parasitic infections in Nigerians. Lancet (1968) 3.22
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
Immunosuppression in children with malaria. Lancet (1972) 3.11
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06
High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03
Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia. Bull World Health Organ (1997) 3.00
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83
Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet (1974) 2.83
Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis (1999) 2.79
Corneal ulceration following measles in Nigerian children. Br J Ophthalmol (1979) 2.79
Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease. Trans R Soc Trop Med Hyg (1969) 2.78
Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75
Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet (1993) 2.74
The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J (1994) 2.73
Carriage of pneumococci after pneumococcal vaccination. Lancet (1996) 2.69
Placental malaria. I. Pathological classification. Histopathology (1993) 2.62
Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg (1983) 2.57
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg (2001) 2.54
Assessment of clinical criteria for identification of severe acute lower respiratory tract infections in children. Lancet (1989) 2.51
Malaria at Christmas: risks of prophylaxis versus risks of malaria. BMJ (1998) 2.48
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44
Deaths in infancy and early childhood in a well-vaccinated, rural, West African population. Ann Trop Paediatr (1987) 2.42
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol (1989) 2.41
The limitations of verbal autopsy in a malaria-endemic region. Ann Trop Paediatr (1994) 2.40
Permethrin-treated bed nets (mosquito nets) prevent malaria in Gambian children. Trans R Soc Trop Med Hyg (1988) 2.40
Treponemal infection and the outcome of pregnancy in a rural area of The Gambia, west Africa. J Infect Dis (1992) 2.39
Impairment of the immune response to vaccination after acute malaria. Lancet (1978) 2.39
Fever as the presenting complaint of travellers returning from the tropics. QJM (1995) 2.34
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect. Ann Rheum Dis (1997) 2.33
Diffuse cutaneous leishmaniasis in Ethiopia. 3. Immunological studies. IV. Pathogenesis of diffuse cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1970) 2.32
Pallor as a clinical sign of severe anaemia in children: an investigation in the Gambia. Bull World Health Organ (1997) 2.28
Complement and meningococcal infection. Br Med J (1976) 2.28
Lesions of schistosomiasis mimicking warts on the vulva. BMJ (1993) 2.25
Evidence for a malaria mitogen in human malaria. Nature (1975) 2.25
Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet (2000) 2.24
Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis (1987) 2.23
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Do bedbugs transmit hepatitis B? Lancet (1994) 2.17
Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15
The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci (1993) 2.12
Disappearance of immunoglobulin and complement from the Arthus reaction and its relevance to studies of vasculitis in man. Br J Dermatol (1971) 2.11
Changes in the pattern of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993. Trop Med Int Health (1997) 2.09
Immunosuppression in murine malaria. II. The effect on reticulo-endothelial and germinal centre function. Clin Exp Immunol (1971) 2.08
Malaria susceptibility and CD36 mutation. Nature (2000) 2.07
Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg (1992) 2.06
What level of hepatitis B antibody is protective? J Infect Dis (1999) 2.02
Polyarthritis in Western Nigeria. I. Rheumatoid arthritis. Ann Rheum Dis (1969) 2.01
Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol (1983) 2.00
Risk factors for mortality from acute lower respiratory tract infections in young Gambian children. Int J Epidemiol (1993) 1.99
Adverse reactions in expatriates treated with ivermectin. Lancet (1990) 1.98
Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa. J Infect Dis (1989) 1.98
Genital and neonatal chlamydial infection in a trachoma endemic area. Lancet (1982) 1.94
Cell-mediated immunity during natural measles infection. J Clin Invest (1978) 1.93
Hepatitis B virus infection in two Gambian villages. Lancet (1983) 1.92
The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J Infect Dis (1982) 1.89
Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet (1991) 1.87
HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet (1991) 1.86
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86
Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities. J Infect Dis (1994) 1.85
Seasonal variation of paediatric diseases in The Gambia, west Africa. Ann Trop Paediatr (1993) 1.85
The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia. Trans R Soc Trop Med Hyg (1996) 1.84
An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa. Soc Sci Med (1999) 1.84
Socio-economic risk factors for malaria in a peri-urban area of The Gambia. Trans R Soc Trop Med Hyg (1995) 1.83
Malaria prevalence is inversely related to vector density in The Gambia, West Africa. Trans R Soc Trop Med Hyg (1995) 1.82
Mortality from pneumococcal meningitis. Lancet (1976) 1.81